Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, [100 or 1000 ] Capsules per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC 100 Count bottle: 0527-1632-01; NDC 1,000 bottle: 0527-1632-10
Published January 25, 2023 · Recall initiated: November 9, 2022
Summary
FDA records drug Class III recall D-0161-2023, published January 25, 2023 and initiated November 9, 2022. Recalling firm: Lannett Company Inc.; Status: Terminated; Reported quantity: 20,040 bottles; Lot: Lots: 21000279A (exp 01/2023), 20256320A (12/2022). Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurity/Degradation Specifications
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Lannett Company Inc.
- Distributor
- Nationwide USA
- Lot
- Lots: 21000279A (exp 01/2023), 20256320A (12/2022)
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and AmphetamineJuly 8, 2026
- FDANiacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed by: Lannett Company,June 10, 2026
- FDAPrimidone Tablets USP, 250mg, 100-count bottle, Rx only, Distributed by: Lannett Company, Inc., Philadelphia,May 27, 2026
- FDANiacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle, Distributed by: LannettOctober 29, 2025
- FDATriamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, 1000 Capsules per bottle,January 25, 2023
- FDALevofloxacin Tablets, USP 500 mg; 50-count bottles, Rx Only, Manufactured for: Macleods Pharma USA, Inc.January 25, 2023
Questions about this recall
Was Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, [100 or 1000 ] Capsules per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC 100 Count bottle: 0527-1632-01; NDC 1,000 bottle: 0527-1632-10 recalled?
Yes. FDA published recall D-0161-2023 on January 25, 2023. Reported hazard: Failed Impurity/Degradation Specifications
What should I do if I have this product?
Voluntary: Firm initiated · Letter